A retrospective evaluation of the effect of oclacitinib (Apoquel) administration on development of surgical site infection following clean orthopedic stifle surgery.

PLoS One · 2023 · PMC10411735 · PMID 37556416

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

approached significancep = 0.053so close (0.05 < p ≤ 0.1)

In multivariate analysis, treatment with oclacitinib approached significance for development of an SSI (p = 0.053) and the odds of developing an SSI 2.944 times higher while on oclacitinib than if not.

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.